Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Li Zhang
Institution:
Qiqihar Medical University
Observed institutions:
Chongqing University,
Zhengzhou University,
Peking University Cancer Hospital,
Henan Cancer Hospital,
The Sixth People's Hospital of Shenyang,
Qiqihar Medical University
show all 6
ORCID:
0000-0002-7068-0940
Observed ORCID:
0000-0002-7068-0940
OpenAlex ID:
A5036891233
Phase 2 Study of the PD-1 Inhibitor Serplulimab plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular Carcinoma
2022
·
Zhenggang Ren
, Guoliang Shao
, et al.
·
Liver Cancer
·
16
PDF
Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma
2025
·
Zhenggang Ren
, Guoliang Shao
, et al.
·
Cancer Immunology Immunotherapy
·
5
PDF
Endoscopic variceal ligation combined with carvedilol versus endoscopic variceal ligation combined with propranolol for the treatment of oesophageal variceal bleeding in cirrhosis: study protocol for a multicentre, randomised controlled trial
2025
·
Yiling Li
, Li Du
, et al.
·
BMJ Open
·
2
Radical chemoradiotherapy for superficial esophageal cancer complicated with liver cirrhosis
2024
·
Hejing Bao
, Hehong Bao
, et al.
·
PeerJ
·
1
β-Asarone, Tenuifolin, and YuanZhi Decoction Restore Cognitive Function and Modulate GRIN2B-Associated Autophagy in Alzheimer’s Disease
2026
·
Haimin Tang
, Fang Peng
, et al.
·
Neurochemical Research
Show more works
View as search
Works count:
6
Citation count:
29
H-index:
3
I10-index:
1
Year
Topic
Type